IL221141A - Methods for the synthesis and isolation of n- (bromoacetyl) -3,3-dinitroazetidine and its preparation - Google Patents

Methods for the synthesis and isolation of n- (bromoacetyl) -3,3-dinitroazetidine and its preparation

Info

Publication number
IL221141A
IL221141A IL221141A IL22114112A IL221141A IL 221141 A IL221141 A IL 221141A IL 221141 A IL221141 A IL 221141A IL 22114112 A IL22114112 A IL 22114112A IL 221141 A IL221141 A IL 221141A
Authority
IL
Israel
Prior art keywords
dinitroazetidine
bromoacetyl
synthesizing
isolating
methods
Prior art date
Application number
IL221141A
Other languages
English (en)
Hebrew (he)
Other versions
IL221141A0 (en
Original Assignee
Orbital Atk Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orbital Atk Inc filed Critical Orbital Atk Inc
Publication of IL221141A0 publication Critical patent/IL221141A0/en
Publication of IL221141A publication Critical patent/IL221141A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL221141A 2010-02-09 2012-07-26 Methods for the synthesis and isolation of n- (bromoacetyl) -3,3-dinitroazetidine and its preparation IL221141A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/702,782 US8471041B2 (en) 2010-02-09 2010-02-09 Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
PCT/US2011/021500 WO2011100090A1 (en) 2010-02-09 2011-01-18 Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same

Publications (2)

Publication Number Publication Date
IL221141A0 IL221141A0 (en) 2012-09-24
IL221141A true IL221141A (en) 2016-08-31

Family

ID=43875262

Family Applications (1)

Application Number Title Priority Date Filing Date
IL221141A IL221141A (en) 2010-02-09 2012-07-26 Methods for the synthesis and isolation of n- (bromoacetyl) -3,3-dinitroazetidine and its preparation

Country Status (12)

Country Link
US (1) US8471041B2 (cg-RX-API-DMAC7.html)
EP (1) EP2534131B1 (cg-RX-API-DMAC7.html)
JP (1) JP5461712B2 (cg-RX-API-DMAC7.html)
KR (1) KR101456438B1 (cg-RX-API-DMAC7.html)
CN (1) CN102762535B (cg-RX-API-DMAC7.html)
AU (1) AU2011216176B2 (cg-RX-API-DMAC7.html)
CA (1) CA2788459C (cg-RX-API-DMAC7.html)
DK (1) DK2534131T3 (cg-RX-API-DMAC7.html)
ES (1) ES2460040T3 (cg-RX-API-DMAC7.html)
IL (1) IL221141A (cg-RX-API-DMAC7.html)
MX (1) MX2012008989A (cg-RX-API-DMAC7.html)
WO (1) WO2011100090A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070135380A1 (en) 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US8664247B2 (en) 2011-08-26 2014-03-04 Radiorx, Inc. Acyclic organonitro compounds for use in treating cancer
US20140308260A1 (en) 2011-10-07 2014-10-16 Radiorx, Inc. Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
ES2935573T3 (es) 2011-10-07 2023-03-08 Epicentrx Inc Compuestos de organonitro tioéter y usos médicos de estos
US10342778B1 (en) 2015-10-20 2019-07-09 Epicentrx, Inc. Treatment of brain metastases using organonitro compound combination therapy
US9987270B1 (en) 2015-10-29 2018-06-05 Epicentrix, Inc. Treatment of gliomas using organonitro compound combination therapy
KR20190040931A (ko) 2016-01-11 2019-04-19 에피센트알엑스, 인코포레이티드 2-브로모-1-(3,3-디니트로아제티딘-1-일)에타논의 정맥내 투여를 위한 조성물 및 방법
EP3526195A4 (en) 2016-10-14 2020-05-20 EpicentRx, Inc. SULFOXYALKYLE ORGANONITRO, RELATED COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR USE IN MEDICINE
IL271777B2 (en) 2017-07-07 2024-09-01 Epicentrx Inc Compositions for parenteral administration of therapeutic agents
US11510901B2 (en) 2018-01-08 2022-11-29 Epicentrx, Inc. Methods and compositions utilizing RRx-001 combination therapy for radioprotection
MX2023014676A (es) * 2021-06-09 2024-02-06 Epicentrx Inc Composiciones de abdnaz cristalinas y metodos de elaboracion y uso de estas.
WO2024145484A1 (en) 2022-12-29 2024-07-04 Epicentrx, Inc. Rrx-001 for treating reproductive-related disorders

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4935450A (en) 1982-09-17 1990-06-19 Therapeutical Systems Corporation Cancer therapy system for effecting oncolysis of malignant neoplasms
JPS60116642A (ja) 1983-11-29 1985-06-24 Nippon Kayaku Co Ltd ２−モノ−置換メチル−５，５−ジメチル−シクロ−２−ヘキセノン誘導体
GB8504253D0 (en) * 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
GB8728418D0 (en) * 1987-12-04 1988-01-13 Jenkins T C Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5693794A (en) * 1988-09-30 1997-12-02 The United States Of America As Represented By The Secretary Of The Navy Caged polynitramine compound
JP2659614B2 (ja) * 1990-11-13 1997-09-30 株式会社日立製作所 表示制御装置
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5336784A (en) * 1993-06-07 1994-08-09 The Regents Of The University Of California Synthesis of 1,3,3-trinitroazetidine
ES2092460T3 (es) 1994-05-27 2001-02-01 Cellegy Pharma Inc Composicion dadora de oxido nitrico para el tratamiento de trastornos anales.
ES2177771T3 (es) * 1995-03-14 2002-12-16 Siemens Ag Dispositivo atomizador ultrasonico con unidad desmontable de dosificacion de precision.
NZ304009A (en) * 1995-03-14 1999-02-25 Siemens Ag Ultrasonic atomizer device with a removable precision dosating unit
US5580988A (en) * 1995-05-15 1996-12-03 The United States Of America As Represented By The Secretary Of The Army Substituted azetidines and processes of using them
AU5798996A (en) 1995-05-15 1996-11-29 Sachs, Michael C. Adnaz, compositions and processes
US5898038A (en) * 1996-03-19 1999-04-27 Board Of Regents, The University Of Texas System Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors
AU3129097A (en) 1996-10-15 1998-05-11 Eastman Chemical Company Explosive formulations
GB9720797D0 (en) 1997-09-30 1997-12-03 Rhodes John Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
AU750313B2 (en) 1998-07-27 2002-07-18 St. Jude Pharmaceuticals, Inc. Chemically induced intracellular hyperthermia
US6448253B1 (en) * 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
US6245799B1 (en) * 1999-11-08 2001-06-12 American Home Products Corp [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
HRP20020808A2 (en) 2000-04-10 2004-12-31 Pfizer Prod Inc Benzoamide piperidine containing compounds and related compounds
US6861530B2 (en) * 2000-07-07 2005-03-01 Kyowa Hakko Kogyo Co., Ltd. Piperidine derivatives
DE10111049A1 (de) 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
EP1336602A1 (en) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
AU2003247792B2 (en) * 2002-07-03 2009-09-24 Nicox S.A. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
AU2003282534A1 (en) * 2002-10-07 2004-05-04 Radiorx, Inc. X-nitro compounds, pharmaceutical compositions thereof and uses therof
US6870061B2 (en) * 2003-01-10 2005-03-22 Alliant Techsystems Inc. Continuous process and system for production of glycidyl nitrate from glycerin, nitric acid and caustic and conversion of glycidyl nitrate to poly(glycidyl nitrate)
AU2004237574A1 (en) 2003-03-13 2004-11-18 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
EP1646608B1 (en) 2003-06-25 2011-03-02 JE IL Pharmaceutical Co., Ltd. Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
GB0326047D0 (en) 2003-11-07 2003-12-10 Univ Sheffield Substance
JP2008512490A (ja) * 2004-09-08 2008-04-24 チェルシー・セラピューティクス，インコーポレイテッド 異常細胞増殖および炎症の障害を治療するための代謝的に不活性な葉酸拮抗剤
US7507842B2 (en) * 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US20070135380A1 (en) 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
BRPI0616755A2 (pt) * 2005-09-27 2011-06-28 Novartis Ag compostos de carboxiamina e métodos de uso dos mesmos
KR100967848B1 (ko) * 2008-05-28 2010-07-05 국방과학연구소 분자화약이 도입된, 고에너지 결합제용1-글리시딜-3,3-디니트로아제티딘 및 그의 제조방법
WO2012078992A1 (en) * 2010-12-09 2012-06-14 Radiorx, Inc. Organonitro compounds for use in treating non-hodgkin's lymphoma and leukemia, and methods relating thereto

Also Published As

Publication number Publication date
KR101456438B1 (ko) 2014-10-31
AU2011216176A1 (en) 2012-08-23
CN102762535B (zh) 2014-09-03
EP2534131A1 (en) 2012-12-19
MX2012008989A (es) 2012-08-23
IL221141A0 (en) 2012-09-24
CA2788459A1 (en) 2011-08-18
ES2460040T3 (es) 2014-05-13
JP2013518925A (ja) 2013-05-23
JP5461712B2 (ja) 2014-04-02
DK2534131T3 (da) 2014-04-07
WO2011100090A1 (en) 2011-08-18
CA2788459C (en) 2016-01-05
AU2011216176B2 (en) 2013-11-14
US20110195947A1 (en) 2011-08-11
EP2534131B1 (en) 2014-03-19
US8471041B2 (en) 2013-06-25
CN102762535A (zh) 2012-10-31
KR20130053385A (ko) 2013-05-23

Similar Documents

Publication Publication Date Title
IL221141A0 (en) Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
GB201006340D0 (en) Synthesis method and intermediates
PT2534136T (pt) Métodos para sintetizar agentes de imagiologia, e seus intermediários
ZA201209475B (en) Compositions comprising a near terminal-branched compound and methods of making the same
SMT202200371T1 (it) Determinate triazolopirazine, loro composizioni e loro metodi d'uso
SG10201506492PA (en) Improved antibodies of the class igg4
IL227035B (en) Aminoindan amide compounds, preparations containing them and their uses
ZA201201542B (en) Novel polymorphs of rebaudioside c and methods for making and using the same
ZA201200226B (en) Opsin-binding ligands, compositions and methods of use
IL202664A (en) Processes for Preparation of 3-Dihlomethyl-1-Methyl-1H-Pyrazole-4-Carbaldehyde and Intermediates
ZA201208770B (en) New forms of rifaximin and uses thereof
ZA201108292B (en) New compounds,pharmaceutical composition and methods relating thereto
IL215153A0 (en) Amide derivative compounds, compositions comprising the same and uses there of
IL223066A0 (en) New process for the synthesis of tapentadol and intermediates thereof
IL220586A (en) Carboxamide compound, a pharmaceutical composition containing it and its use
ZA201206517B (en) Acetaminophen composition
EP2576556A4 (en) PROCESS FOR SYNTHESIZING CARBONUCLEOSIDE AND PARTICIPATING INTERMEDIATES
IL226174A0 (en) Impulse preparations and methods for their preparation
GB0909768D0 (en) Novel compounds and uses thereof
EP2626347A4 (en) DALFAMPRIDINPOLYMORPH AND THE PREPARATION AND USE THEREOF
EP2643308A4 (en) PROCESS FOR THE PREPARATION OF TAUROLIDINE AND ITS INTERMEDIATE PRODUCTS
GB201020357D0 (en) Compounds and methods of making the same
GB201004450D0 (en) Compounds and methods relating thereto
IL222981A0 (en) Compound, synthesis, composition and uses thereof
HK1177104A (en) New forms of rifaximin and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed